title: Greenlight™ photovaporization of the prostate in patients under rivaroxaban: Lesson learned after the first cases.
authors.affiliation: EA 4564 "Modélisation de l'agression tissulaire et nociceptive", université Paul-Sabatier, 31000 Toulouse, France; Pôle anesthésie-réanimation, CHU Purpan, place du Dr-Baylac, 31059 Toulouse cedex 9, France. Electronic address: helenecharbs@hotmail.com.
authors.forename: H
authors.initials: H
authors.lastname: Charbonneau
authors.affiliation: Department of cardiovascular medicine, clinique Pasteur, 31300 Toulouse, France.
authors.forename: A
authors.initials: A
authors.lastname: Pathak
authors.affiliation: Department of cardiovascular medicine, clinique Pasteur, 31300 Toulouse, France.
authors.forename: J-P
authors.initials: JP
authors.lastname: Albenque
authors.affiliation: Department of urology, clinique Pasteur, 31300 Toulouse, France.
authors.forename: V
authors.initials: V
authors.lastname: Misrai
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D065427:Factor Xa Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D053685:Laser Therapy / Q000379:methods; D008297:Male; D009765:Obesity / Q000150:complications; D011468:Prostatectomy / Q000379:methods; D011470:Prostatic Hyperplasia / Q000150:complications / Q000628:therapy*; D012307:Risk Factors; D000069552:Rivaroxaban / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban
keywords: Anticoagulants; Benign prostatic obstruction; Hyperplasie bénigne de prostate; Laser; Laser therapy; Oral anticoagulation; Prostate; Surgery